As of 2025-03-16, the Relative Valuation of Oncolytics Biotech Inc (ONC.TO) is (0.03) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.90 CAD, the upside of Oncolytics Biotech Inc based on Relative Valuation is -103.8%.
The range of the Relative Valuation is (0.03) - (0.07) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.2x | 0.1x |
| Forward P/E multiples | 0.1x - 0.2x | 0.1x |
| Fair Price | (0.03) - (0.07) | (0.03) |
| Upside | -103.1% - -107.7% | -103.8% |
| Date | P/E |
| 2025-02-24 | -2.95 |
| 2025-02-21 | -2.98 |
| 2025-02-20 | -3.04 |
| 2025-02-19 | -2.98 |
| 2025-02-18 | -3.10 |
| 2025-02-14 | -3.21 |
| 2025-02-13 | -3.18 |
| 2025-02-12 | -3.21 |
| 2025-02-11 | -3.16 |
| 2025-02-10 | -3.13 |
| 2025-02-07 | -3.16 |
| 2025-02-06 | -3.30 |
| 2025-02-05 | -3.04 |
| 2025-02-04 | -2.95 |
| 2025-02-03 | -2.92 |
| 2025-01-31 | -3.10 |
| 2025-01-30 | -3.07 |
| 2025-01-29 | -3.04 |
| 2025-01-28 | -3.13 |
| 2025-01-27 | -3.04 |
| 2025-01-24 | -3.27 |
| 2025-01-23 | -3.39 |
| 2025-01-22 | -3.62 |
| 2025-01-21 | -3.44 |
| 2025-01-20 | -3.42 |
| 2025-01-17 | -3.36 |
| 2025-01-16 | -3.50 |
| 2025-01-15 | -3.39 |
| 2025-01-14 | -3.39 |
| 2025-01-13 | -3.50 |
| 2025-01-10 | -3.62 |
| 2025-01-09 | -3.76 |
| 2025-01-08 | -3.65 |
| 2025-01-07 | -3.91 |
| 2025-01-06 | -3.91 |
| 2025-01-03 | -4.05 |
| 2025-01-02 | -3.82 |
| 2024-12-31 | -3.85 |
| 2024-12-30 | -3.88 |
| 2024-12-27 | -4.14 |
| 2024-12-24 | -4.08 |
| 2024-12-23 | -3.73 |
| 2024-12-20 | -3.44 |
| 2024-12-19 | -3.79 |
| 2024-12-18 | -3.18 |
| 2024-12-17 | -3.27 |
| 2024-12-16 | -3.42 |
| 2024-12-13 | -3.42 |
| 2024-12-12 | -3.47 |
| 2024-12-11 | -3.53 |